Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease

Journal of Inflammation

Anthony Michael Dart⁴  Flavia Cicuttini⁴  Miles Sparrow¹  Xiao-lei Moore²  David Andrew White²  Lu Fang²  Abby Galvin²  Fenling Fan³ 

[1] Department of Gastroenterology, The Alfred Hospital, Commercial Road, Melbourne 3004, VIC, Australia;Baker IDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne 3004, VIC, Australia;Department of Cardiovascular Medicine, The 1st Affiliated Hospital of Medical College, Xi¿an Jiaotong University, Xi¿an 710061, China;Department of Epidemiology and Preventative Medicine, Monash University, Melbourne 3800, VIC, Australia

关键词: Pulse wave velocity;    Arterial stiffness;    Inflammatory bowel disease;    Rheumatoid arthritis;    Inflammation;   

Others  :  1140764
DOI  :  10.1186/s12950-014-0029-0

 received in 2014-04-09, accepted in 2014-09-28,  发布年份 2014

【 摘 要 】

Background

Inflammation plays an important role in the pathogenesis of atherosclerosis. The link between rheumatoid arthritis (RA) and an increased risk of cardiovascular disease and mortality is well established; however, the association between inflammatory bowel disease (IBD) and cardiovascular risk is controversial. Arterial stiffness is both a marker and risk factor for atherosclerosis. Here we aimed to 1) compare circulating markers of inflammation and endothelial dysfunction, traditional cardiovascular risk factors, and arterial stiffness between RA and IBD to help to understand their different associations with cardiovascular disease; 2) assess the impacts of circulating markers of inflammation and endothelial dysfunction, and traditional risk factors on arterial stiffness.

Methods

Patients with RA (n?=?43) and IBD (n?=?42), and control subjects (n?=?73) were recruited. Plasma inflammatory markers and von Willebrand factor (vWF) were measured by Multiplex assays or ELISA. Arterial stiffness was determined by brachial-ankle pulse wave velocity (baPWV) and ankle-brachial index (ABI) was measured. Framingham Risk Score (FRS) was calculated, and other traditional risk factors were also documented.

Results

Plasma levels of several inflammatory markers and vWF were significantly but comparably elevated in RA and IBD compared with controls, except for a higher level of C-reactive protein (CRP) in RA than IBD. Compared to controls, FRS, body mass index, waist circumference, and triglycerides were increased in RA, but not in IBD. baPWV did not significantly differ among 3 groups, while ABI was modestly but significantly lower in IBD than controls. Circulating markers (macrophage migration inhibitory factor, tumour necrosis factor-?, CRP, and vWF) were significantly associated with baPWV. However, traditional risk factors (age, systolic blood pressure, body mass index, diabetes and triglycerides) were the parameters associated with baPWV in multiple regression analyses (overall r?=?0.866, p?

Conclusions

RA has a higher level of CRP and more pronounced traditional cardiovascular risk factors than IBD, which may contribute to the difference in their associations with cardiovascular disease and mortality. Traditional risk factors, rather than inflammation markers, are major predictors of arterial stiffness even in subjects with inflammatory disorders. Our results point to the importance of modifying traditional risk factors in patients with inflammatory disorders.

【 授权许可】

   
2014 Fan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Libby P, Ridker PM, Hansson GK: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
• [2]Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J: C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
• [3]Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG: C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh artery study. Circulation 2005, 112:976-983.
• [4]Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
• [5]del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737-2745.
• [6]Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV: Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006, 33:2167-2172.
• [7]Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D: Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008, 59:1690-1697.
• [8]Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D: Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012, 71:1524-1529.
• [9]Jess T, Gamborg M, Munkholm P, Sorensen TI: Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007, 102:609-617.
• [10]Dorn SD, Sandler RS: Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol 2007, 102:662-667.
• [11]Ha C, Magowan S, Accortt NA, Chen J, Stone CD: Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009, 104:1445-1451.
• [12]Bernstein CN, Wajda A, Blanchard JF: The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008, 6:41-45.
• [13]Dart AM, Lacombe F, Yeoh JK, Cameron JD, Jennings GL, Laufer E, Esmore DS: Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet 1991, 338:270-273.
• [14]Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a ¿set up¿ for vascular disease. Circulation 2003, 107:139-146.
• [15]Dart AM, Kingwell BA: Pulse pressure¿a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001, 37:975-984.
• [16]Munakata MNT, Tayama J, Yoshinaga K, Toyota T: Brachial-Ankle pulse wave velocity as a novel measure of arterial stiffness: present evidences and perspectives. Curr Hypertens Rev 2005, 1:223-234.
• [17]Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003, 26:615-622.
• [18]Mancini GB, Dahlof B, Diez J: Surrogate markers for cardiovascular disease: structural markers. Circulation 2004, 109:IV22-IV30.
• [19]Heald CL, Fowkes FG, Murray GD, Price JF: Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006, 189:61-69.
• [20]Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
• [21]Montes M, Jaensson EA, Orozco AF, Lewis DE, Corry DB: A general method for bead-enhanced quantitation by flow cytometry. J Immunol Methods 2006, 317:45-55.
• [22]Osterman MT, Yang YX, Brensinger C, Forde KA, Lichtenstein GR, Lewis JD: No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn¿s disease. Clin Gastroenterol Hepatol 2011, 9:875-880.
• [23]Andersohn F, Waring M, Garbe E: Risk of ischemic stroke in patients with Crohn¿s disease: a population-based nested case-control study. Inflamm Bowel Dis 2011, 16:1387-1392.
• [24]Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA: Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011, 106:741-747.
• [25]Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T: Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut 2012, 62:689-694.
• [26]Fumery M, Xiaocang C, Dauchet L, Gower-Rousseau C, Peyrin-Biroulet L, Colombel JF: Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis 2014, 8:469-479.
• [27]Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ: Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 2005, 52:2293-2299.
• [28]Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
• [29]Chung CP, Giles JT, Petri M, Szklo M, Post W, Blumenthal RS, Gelber AC, Ouyang P, Jenny NS, Bathon JM: Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum 2012, 41:535-544.
• [30]Sappati Biyyani RS, Fahmy NM, Baum E, Nelson KM, King JF: Inflammatory bowel disease and coronary artery disease. Indian J Gastroenterol 2009, 28:28-30.
• [31]Gandhi S, Narula N, Marshall JK, Farkouh M: Are patients with inflammatory bowel disease at increased risk of coronary artery disease? Am J Med 2012, 125:956-962.
• [32]Theocharidou E, Mavroudi M, Soufleris K, Griva T, Giouleme O, Athyros VG, Karagiannis A: Aortic stiffness in patients with inflammatory bowel diseases. Hellenic J Atherosclerosis 2013, 4:200-207.
• [33]Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM: Inflammation, immunity, and hypertension. Hypertension 2011, 57:132-140.
• [34]Gregor MF, Hotamisligil GS: Inflammatory mechanisms in obesity. Annu Rev Immunol 2011, 29:415-445.
• [35]Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
• [36]Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005, 11:191-198.
• [37]Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
• [38]Esteve E, Ricart W, Fernandez-Real JM: Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005, 24:16-31.
• [39]McGillicuddy FC, de la Llera MM, Hinkle CC, Joshi MR, Chiquoine EH, Billheimer JT, Rothblat GH, Reilly MP: Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009, 119:1135-1145.
• [40]Maki-Petaja KM, Hall FC, Booth AD, Wallace SM, Yasmin , Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB: Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 2006, 114:1185-1192.
• [41]Protogerou AD, Zampeli E, Fragiadaki K, Stamatelopoulos K, Papamichael C, Sfikakis PP: A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis. Atherosclerosis 2011, 219:734-736.
• [42]Zanoli L, Cannavo M, Rastelli S, Di Pino L, Monte I, Di Gangi M, Boutouyrie P, Inserra G, Laurent S, Castellino P: Arterial stiffness is increased in patients with inflammatory bowel disease. J Hypertens 2012, 30:1775-1781.
• [43]Cypiene A, Laucevicius A, Venalis A, Ryliskyte L, Dadoniene J, Petrulioniene Z, Kovaite M, Laskova V, Gintautas J: Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab). Proc West Pharmacol Soc 2007, 50:119-122.
• [44]Yasmin MECM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB: C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004, 24:969-974.
• [45]Mahmud A, Feely J: Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005, 46:1118-1122.
• [46]Okamura T, Moriyama Y, Kadowaki T, Kanda H, Ueshima H: Non-invasive measurement of brachial-ankle pulse wave velocity is associated with serum C-reactive protein but not with alpha-tocopherol in Japanese middle-aged male workers. Hypertens Res 2004, 27:173-180.
• [47]Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Tepohl G, Haberl RL, Allenberg JR, Dasch B, Trampisch HJ: Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006, 27:1743-1749.
• [48]Criqui MH, Denenberg JO, Langer RD, Fronek A: The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997, 2:221-226.
• [49]Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, Tomiyama H, Yamashina A, Yasuda H, Sawayama T, Ozawa T: Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 2009, 27:2022-2027.
• [50]Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, Emoto M, Nishizawa Y: Brachial-ankle pulse wave velocity as an index of central arterial stiffness. J Atheroscler Thromb 2010, 17:658-665.
• [51]Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, Tanaka H: Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens 2005, 19:401-406.
• [52]Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, Ioakeimidis N, Stefanadis C: Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension 2012, 60:556-562.